Resources
8 Results (showing 1 - 8)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 3/14/2023 (updated 3/27/2024)
Contingency management has empirical support but limited implementation. This report provides an overview of contingency management, barriers of implementation, and recommendation on how to overcome the challenges of implementation. Evidence-based treatment for people with stimulant use disorder is important as the U.S. has been experiencing an overdose crisis resulting in overdose deaths.
Posted 11/17/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) has published the new resource "Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues". This Treatment Improvement Protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use.
Posted 2/19/2024 (updated 3/28/2024)
The Health Affairs Forefront is a way for individuals in the health care industry to "catch up on the ideas that thought leaders and peers are exploring in the field". Recently, contingency management (CM) was discussed, including ways to make the behavioral intervention available to more people. The discussion included what CM is, why it is not more widely available, training considerations, and recommendations on how Federal policy could change to increase the availability.
Posted 11/25/2020 (updated 4/3/2024)
This Peer Integration Toolkit from Office of Addiction Services And Supports State of New York (OASAS) uses a stages of change framework to present guidance information. To effectively implement change, the organization will need to evaluate their current stage of change about the integration of peer services (pre-contemplation, contemplation, preparation, action or wellness).
Posted 12/9/2020 (updated 4/3/2024)
Detailed risk benefit assessment of medications, settings and patient outcomes. These guidelines were developed in response to a resolution from the United Nations Economic and Social Council (ECOSOC), “to develop and publish minimum requirements and international guidelines on psychosocially assisted pharmacological treatment of persons dependent on opioids”
Posted 2/18/2021 (updated 4/4/2024)
Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD.
In this study we sought to assess 3-month outcomes from a patient-centered practice that included MAT with buprenorphine or naltrexone plus the option to participate in psychosocial treatments. The psychosocial treatments included case management, psychotherapy, peer recovery groups such as Narcotics Anonymous or Smart Recovery, or peer support through a local harm reduction program.
Posted 2/24/2021 (updated 4/4/2024)
This webinar provided new information on the risks and clinical challenges presented by individuals who use psychostimulants (cocaine, methamphetamine and prescription stimulants). A review of the clinical strategies that are important in working with this population were presented, including psychosocial and medication treatments for those with stimulant use disorder. Presented by Richard Rawson, Ph.D.
Posted 4/26/2021 (updated 4/10/2024)
A Protocol Using Empirically Supported Behavioral Treatments for People with Psychoactive Stimulant Use Disorders